Litcius/Paper detail

Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study

Sarah H. Lisanby, Shawn M. McClintock, W. Vaughn McCall, Rebecca G. Knapp, C. Munro Cullum, Martina Mueller, Zhi‐De Deng, Abeba A. Teklehaimanot, Matthew V. Rudorfer, Elisabeth Bernhardt, George S. Alexopoulos, Samuel H. Bailine, Mimi C. Briggs, Emma T. Geduldig, Robert M. Greenberg, Mustafa M. Husain, Styliani Kaliora, Vassilios Latoussakis, Lauren S. Liebman, Georgios Petrides, Joan Prudic, Peter B. Rosenquist, Shirlene Sampson, Kristen G. Tobias, Richard D. Weiner, Robert C. Young, Charles H. Kellner

2021American Journal of Geriatric Psychiatry44 citationsDOIOpen Access PDF

Topics & Concepts

NeurocognitivePharmacotherapyElectroconvulsive therapyPsychologyLate life depressionMajor depressive disorderVenlafaxinePsychiatryDepression (economics)Verbal fluency testMoodNeuropsychologyMedicinePediatricsClinical psychologyCognitionAntidepressantAnxietyMacroeconomicsEconomicsElectroconvulsive Therapy StudiesTreatment of Major DepressionTranscranial Magnetic Stimulation Studies
Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study | Litcius